Shares of CSL Fall After Trump Warns of 100% Tariffs on Pharmaceutical Products Imports
MT Newswires Live
Sep 26
Shares of CSL (ASX:CSL) fell past 2% in recent Friday trade after US President Donald Trump warned of a 100% tariff on imports of branded or patented pharmaceutical products, effective Oct.1, unless the company has started construction of a manufacturing plant in the US.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.